spacer
home > white papers > Crunch Time: The Impact of Serialisation Requirements on Packaging Operations - PCI Pharma Services
WHITE PAPERS
logo_PCI_PharmaL.jpg

PCI Pharma Services

phone +44 (0)1495 713 633
email sales@pciservices.com
web http://www.pciservices.com
email Wye Valley Business Park, Hay-on-Wye, HR3 5PG

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

The deadlines for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-prepared to meet the target. Here, we look to the experience of a company that is ahead of the curve for lessons on how to manage and ease the transition to serialisation.
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Molecular Devices adds proprietary patient-derived organoid technology with acquisition of Cellesce

First-of-its-kind technology from Cellesce creates consistent patient-derived organoids for large scale drug screening. Acquisition strengthens Molecular Devicesí position as a 3D biology solutions innovator. Combined expertise will accelerate industry adoption of physiologically-relevant cell models for drug discovery.
More info >>


White Papers

Key to Outsourcing Method Development and Validation A Pragmatic Approach

RSSL

In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developerís mind set and a regulatory background in validation.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement